995 karma · joined May 2, 2017
Nonetheless, excited to see it -- it's something that I've complained about with AWS since using Google's CloudShell. It also continues us down the path to easy Ops-type work on an iPad (even though you can already have an EC2 instance and use Prompt to access it, being able to have a shell without needing to provision and EC2 instance is chefs kiss).
Warp Speed funding to AstraZeneca, Moderna, and Johnson & Johnson also included money that was earmarked for manufacturing capability investment.
Moderna's initial funding didn't have an order attached to it, not that was disclosed. In August the US Government did go back and actually purchase vaccines under a separate agreement (https://www.hhs.gov/about/news/2020/08/11/trump-administrati...). Also:
> The May 21, April 16, and March 30 HHS agreements with AstraZeneca, Moderna, and Johnson & Johnson respectively include investments in manufacturing capabilities.
(https://www.hhs.gov/coronavirus/explaining-operation-warp-sp...)
Not tacking on a service mesh middleware that I now have to manage and debug.
Boundary sounds like the perfect mash-up of Google's bastion-less SSH access to GCE instances and actual IAM. Exciting!
It was until it caused a production outage, then it became very not worth it.
Yep, we (Basecamp) have been bit by this with EKS too. By default the ALB Ingress Controller will put all cluster nodes into the target group and a request can hit kube-proxy in any AZ before being directed to the right place, causing a lot of inter-AZ traffic churn. It's mildly annoying.
(with alb-ingress-controller you can change target-type to IP to have traffic go direct to pods that will actually back a given service instead of via kube-proxy on a random node, but the big fault there is that if alb-ingress-controller gets hung up on something and you deploy, you can send traffic to nowhere because the target group still has old IPs for pods that don't exist).
Interesting approach here, seems to just be offloading the service to Intelsat only to have a rev guarantee which would make the sale profitable with a pretty quick turnaround.
But yes, the long-term effects are the real problem.